594 related articles for article (PubMed ID: 18681906)
41. Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.
Gaur P; Sceusi EL; Samuel S; Xia L; Fan F; Zhou Y; Lu J; Tozzi F; Lopez-Berestein G; Vivas-Mejia P; Rashid A; Fleming JB; Abdalla EK; Curley SA; Vauthey JN; Sood AK; Yao JC; Ellis LM
Gastroenterology; 2011 Nov; 141(5):1728-37. PubMed ID: 21806944
[TBL] [Abstract][Full Text] [Related]
42. The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis.
van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Pelger RC; van der Pluijm G
Clin Exp Metastasis; 2011 Oct; 28(7):615-25. PubMed ID: 21647815
[TBL] [Abstract][Full Text] [Related]
43. Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells.
Hellsten R; Johansson M; Dahlman A; Sterner O; Bjartell A
PLoS One; 2011; 6(7):e22118. PubMed ID: 21779382
[TBL] [Abstract][Full Text] [Related]
44. Scutellarin, a flavonoid compound from Scutellaria barbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice.
Ma H; Yue GG; Lee JK; Gao S; Yuen KK; Cheng W; Li X; Lau CB
Phytomedicine; 2024 Jun; 128():155418. PubMed ID: 38518647
[TBL] [Abstract][Full Text] [Related]
45. Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy.
Paholak HJ; Stevers NO; Chen H; Burnett JP; He M; Korkaya H; McDermott SP; Deol Y; Clouthier SG; Luther T; Li Q; Wicha MS; Sun D
Biomaterials; 2016 Oct; 104():145-57. PubMed ID: 27450902
[TBL] [Abstract][Full Text] [Related]
46. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.
Fillmore CM; Kuperwasser C
Breast Cancer Res; 2008; 10(2):R25. PubMed ID: 18366788
[TBL] [Abstract][Full Text] [Related]
47. Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.
McGowan PM; Simedrea C; Ribot EJ; Foster PJ; Palmieri D; Steeg PS; Allan AL; Chambers AF
Mol Cancer Res; 2011 Jul; 9(7):834-44. PubMed ID: 21665937
[TBL] [Abstract][Full Text] [Related]
48. Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.
Mine T; Matsueda S; Li Y; Tokumitsu H; Gao H; Danes C; Wong KK; Wang X; Ferrone S; Ioannides CG
Cancer Immunol Immunother; 2009 Aug; 58(8):1185-94. PubMed ID: 19048252
[TBL] [Abstract][Full Text] [Related]
49. Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines.
Enciso-Benavides J; Alfaro L; Castañeda-Altamirano C; Rojas N; González-Cabeza J; Enciso N; Riesco F; Castillo M; Enciso J
Heliyon; 2021 Jun; 7(6):e07273. PubMed ID: 34235281
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.
Rasheed ZA; Yang J; Wang Q; Kowalski J; Freed I; Murter C; Hong SM; Koorstra JB; Rajeshkumar NV; He X; Goggins M; Iacobuzio-Donahue C; Berman DM; Laheru D; Jimeno A; Hidalgo M; Maitra A; Matsui W
J Natl Cancer Inst; 2010 Mar; 102(5):340-51. PubMed ID: 20164446
[TBL] [Abstract][Full Text] [Related]
51. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
[TBL] [Abstract][Full Text] [Related]
52. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion.
Yu F; Li J; Chen H; Fu J; Ray S; Huang S; Zheng H; Ai W
Oncogene; 2011 May; 30(18):2161-72. PubMed ID: 21242971
[TBL] [Abstract][Full Text] [Related]
53. Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles.
Sansone P; Berishaj M; Rajasekhar VK; Ceccarelli C; Chang Q; Strillacci A; Savini C; Shapiro L; Bowman RL; Mastroleo C; De Carolis S; Daly L; Benito-Martin A; Perna F; Fabbri N; Healey JH; Spisni E; Cricca M; Lyden D; Bonafé M; Bromberg J
Cancer Res; 2017 Apr; 77(8):1927-1941. PubMed ID: 28202520
[TBL] [Abstract][Full Text] [Related]
54. O-GlcNAc Transferase Regulates Cancer Stem-like Potential of Breast Cancer Cells.
Akella NM; Le Minh G; Ciraku L; Mukherjee A; Bacigalupa ZA; Mukhopadhyay D; Sodi VL; Reginato MJ
Mol Cancer Res; 2020 Apr; 18(4):585-598. PubMed ID: 31974291
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer.
Serrano D; Bleau AM; Fernandez-Garcia I; Fernandez-Marcelo T; Iniesta P; Ortiz-de-Solorzano C; Calvo A
Mol Cancer; 2011 Aug; 10():96. PubMed ID: 21827695
[TBL] [Abstract][Full Text] [Related]
56. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
Wright MH; Calcagno AM; Salcido CD; Carlson MD; Ambudkar SV; Varticovski L
Breast Cancer Res; 2008; 10(1):R10. PubMed ID: 18241344
[TBL] [Abstract][Full Text] [Related]
57. Influence of Aldehyde Dehydrogenase Inhibition on Stemness of Endometrial Cancer Stem Cells.
Serambeque B; Mestre C; Correia-Barros G; Teixo R; Marto CM; Gonçalves AC; Caramelo F; Silva I; Paiva A; Beck HC; Carvalho AS; Botelho MF; Carvalho MJ; Matthiesen R; Laranjo M
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893151
[TBL] [Abstract][Full Text] [Related]
58. Isolation and characterization of a metastatic hybrid cell line generated by ER negative and ER positive breast cancer cells in mouse bone marrow.
Mukhopadhyay KD; Bandyopadhyay A; Chang TT; Elkahloun AG; Cornell JE; Yang J; Goins BA; Yeh IT; Sun LZ
PLoS One; 2011; 6(6):e20473. PubMed ID: 21673810
[TBL] [Abstract][Full Text] [Related]
59. P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer.
Vieira AF; Ricardo S; Ablett MP; Dionísio MR; Mendes N; Albergaria A; Farnie G; Gerhard R; Cameselle-Teijeiro JF; Seruca R; Schmitt F; Clarke RB; Paredes J
Stem Cells; 2012 May; 30(5):854-64. PubMed ID: 22389315
[TBL] [Abstract][Full Text] [Related]
60. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
Ginestier C; Hur MH; Charafe-Jauffret E; Monville F; Dutcher J; Brown M; Jacquemier J; Viens P; Kleer CG; Liu S; Schott A; Hayes D; Birnbaum D; Wicha MS; Dontu G
Cell Stem Cell; 2007 Nov; 1(5):555-67. PubMed ID: 18371393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
